Units

Signal Transduction and Metabolism Laboratory

Metabolic diseases such as obesity, type 1 and 2 diabetes, and liver cancer are major health problems with pandemic proportions. Approximately 650 million adults are obese worldwide, accounting for ~16% of the Belgian adult population. Obesity is a key risk factor for diabetes, cardiovascular disorders, and metabolic dysfunction-associated steatotic liver disease.

One of the main problems in developing valued research that impacts patient care is the absence of interaction between different scientific fields, foundations, and, importantly, external collaborators and industrial partners. The Signal Transduction and Metabolism Laboratory aims to fill this gap in our institution and will be instrumental in establishing the ULB as a top metabolic unit that provides extensive services to companies and external users. In addition, it will help better prepare students for the current and future challenges in metabolic diseases.

Projetcs

This person isn't currently part of a projet.